AKPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Akpro, and what generic alternatives are available?
Akpro is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in AKPRO is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AKPRO?
- What are the global sales for AKPRO?
- What is Average Wholesale Price for AKPRO?
Summary for AKPRO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 53 |
| Patent Applications: | 575 |
| DailyMed Link: | AKPRO at DailyMed |
US Patents and Regulatory Information for AKPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | AKPRO | dipivefrin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074382-001 | Sep 29, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
